TG Therapeutics | TGTX - Ativos





Ativos Alterar Data
AbbVie USD 136.46B 2.5B 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 92.5B 1.92B 2026-03
Ardelyx USD 504.51M 2.9M 2026-03
Arrowhead Research USD 2.27B 664.08M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Biogen USD 29.48B 43.6M 2026-03
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Curis USD 19.97M 9.27M 2025-12
Gilead Sciences USD 56.28B 2.74B 2026-03
J&J USD 200.89B 1.68B 2026-03
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Novavax USD 1.04B 133.35M 2026-03
PTC Therapeutics USD 2.87B 29.66M 2026-03
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.53B 465.58M 2026-03
Verastem USD 246.44M 69.59M 2025-12
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03